Andy
Retired committee member
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) a long-term, complex, debilitating disorder associated with poor health-related quality of life and declined functional status for individuals and a significant economic burden on society. CFS/ME is defined by symptoms and patient’s constraints on daily living is influenced directly by symptoms.
We will develop a core outcome set for CFS/ME following recommendations for developing core outcome set (COS) from COMET (Core Outcome Measures in Effectiveness Trials), COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments), and OMERACT (Outcome Measures in Rheumatology). We will conduct two scoping reviews of qualitative research and interventional studies. To select the most important outcome measures for CFS/ME, after the evidence synthesis, we will use the Delphi process involving patient partners and clinicians in this area and a modified Nominal Group Technique to achieve consensus. The COS for CFS/ME will inform outcomes that are measured and reported in future studies in this area, including systematic reviews, clinical trials, and clinical practice guidelines.
Contributors
Dena Zeraatkar and Jason Busse from McMaster University, Hamilton, Canada
Further Study Information
Current Stage: Ongoing
Date: August 2022 - December 2022
Funding source(s): None
https://www.comet-initiative.org/Studies/Details/2103
We will develop a core outcome set for CFS/ME following recommendations for developing core outcome set (COS) from COMET (Core Outcome Measures in Effectiveness Trials), COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments), and OMERACT (Outcome Measures in Rheumatology). We will conduct two scoping reviews of qualitative research and interventional studies. To select the most important outcome measures for CFS/ME, after the evidence synthesis, we will use the Delphi process involving patient partners and clinicians in this area and a modified Nominal Group Technique to achieve consensus. The COS for CFS/ME will inform outcomes that are measured and reported in future studies in this area, including systematic reviews, clinical trials, and clinical practice guidelines.
Contributors
Dena Zeraatkar and Jason Busse from McMaster University, Hamilton, Canada
Further Study Information
Current Stage: Ongoing
Date: August 2022 - December 2022
Funding source(s): None
https://www.comet-initiative.org/Studies/Details/2103